Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam versus propofol for sedation in foot and ankle fracture surgery
ChiCTR2600118961Phase 4Not yet recruiting
- Sponsor
- Foshan Hospital of Traditional Chinese Medicine
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in Foot fracture and ankle fracture (2 arms), sponsored by Foshan Hospital of Traditional Chinese Medicine. Primary endpoint: Intraoperative incidence of subclinical respiratory depression. Planned start Feb 2026; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
Foot fractureankle fracture
Beyond the preview
Go deeper on ChiCTR2600118961.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600118961.